Breakdown | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 30.93B | 23.51B | 19.91B | 14.75B | 26.48B |
Gross Profit | 10.05B | 8.65B | 5.93B | 4.82B | 4.73B |
EBITDA | 6.70B | 5.80B | 3.04B | 2.16B | 1.84B |
Net Income | 3.94B | 3.30B | 1.64B | 953.00M | 344.00M |
Balance Sheet | |||||
Total Assets | 56.90B | 57.24B | 56.01B | 48.75B | 45.96B |
Cash, Cash Equivalents and Short-Term Investments | 12.80B | 10.80B | 11.21B | 13.24B | 12.61B |
Total Debt | 34.35B | 37.11B | 40.22B | 36.16B | 35.61B |
Total Liabilities | 39.23B | 42.20B | 43.96B | 38.12B | 37.92B |
Stockholders Equity | 17.66B | 14.72B | 12.01B | 10.61B | 8.03B |
Cash Flow | |||||
Free Cash Flow | 5.82B | 4.88B | -4.09B | 167.00M | -7.22B |
Operating Cash Flow | 6.15B | 5.01B | -4.05B | 298.00M | -7.12B |
Investing Cash Flow | 18.00M | -78.00M | -1.98B | 260.00M | 432.00M |
Financing Cash Flow | -4.27B | -4.68B | 3.76B | 2.08B | 11.85B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | ¥25.26B | 11.96 | 3.21% | 30.61% | 16.32% | ||
76 Outperform | ¥28.17B | 6.68 | 4.22% | 67.30% | 35.56% | ||
70 Outperform | ¥24.65B | 5.20 | 3.94% | 2.94% | 4.03% | ||
68 Neutral | ¥23.30B | 8.57 | 3.78% | 12.14% | 4.17% | ||
67 Neutral | ¥22.66B | 8.04 | 4.17% | 3.93% | 26.84% | ||
66 Neutral | £955.68M | 13.95 | 2.04% | 110.45% | 11.04% | 38.13% | |
62 Neutral | ¥21.42B | 7.29 | 2.89% | 14.69% | -23.39% |